Literature DB >> 27956179

MiR-141-3p promotes prostate cancer cell proliferation through inhibiting kruppel-like factor-9 expression.

Jiu-Zhi Li1, Jia Li2, Hui-Qin Wang3, Xun Li4, Bin Wen4, Yu-Jie Wang5.   

Abstract

Evidence has revealed that some microRNAs play a critical role in tumor proliferation. We demonstrated that miR-141-3p appears to be a novel oncogene miRNA, which promotes prostate tumorigenesis and facilitates the stemness of prostate cancer cells via suppressing a key transcription factor kruppel-like factor-9 (KLF9). KLF9 is the core effector protein that might suppress tumor growth. MiR-141-3p is upregulated in prostate cancer cells and tissues compared to non-tumorigenic prostate epithelial cells and prostate tissues. MiR-141-3p positively regulated proliferation, spheroid formation, and expression of the stemness factors OCT-4, Nanog, SOX-9, Bmil, CCND1, and CD44 in PC-3 cells. Restoration of miR-141-3p suppresses the expression of the transcription factor KLF9 in PC-3 and accelerates prostate tumorigenesis via targeted binding with its 3'-UTR. Downregulation of KLF9 enhances spheres formation of prostate cancer cells. Our results suggest that miR-141-3p/KLF9 may play an important role in regulating the growth of prostate cancer and is a potential target of prevention and therapy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  KLF9; MiR-141-3p; Proliferation; Prostate cancer; Stemness

Mesh:

Substances:

Year:  2016        PMID: 27956179     DOI: 10.1016/j.bbrc.2016.12.045

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  miR-202 suppresses prostate cancer growth and metastasis by targeting PIK3CA.

Authors:  Shengping Zhang; Jiarong Cai; Wenjun Xie; Hui Luo; Fei Yang
Journal:  Exp Ther Med       Date:  2018-06-12       Impact factor: 2.447

2.  Expression of miR-141 and YAP1 in gastric carcinoma and modulation of cancer cell proliferation and apoptosis.

Authors:  Fangchao Du; Chao Yu; Rui Li; Ding Ding; Lei He; Gang Wen
Journal:  Int J Clin Exp Pathol       Date:  2019-02-01

Review 3.  LncRNA-miRNA-mRNA regulatory axes in endometrial cancer: a comprehensive overview.

Authors:  Abhishek Shetty; Thejaswini Venkatesh; Shama Prasada Kabbekodu; Rie Tsutsumi; Padmanaban S Suresh
Journal:  Arch Gynecol Obstet       Date:  2022-02-18       Impact factor: 2.493

4.  Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer.

Authors:  Muralidharan Jayaraman; Rangasudhagar Radhakrishnan; Cara A Mathews; Mingda Yan; Sanam Husain; Katherine M Moxley; Yong Sang Song; Danny N Dhanasekaran
Journal:  Genes Cancer       Date:  2017-05

5.  Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer.

Authors:  Binod Kumar; Avi Z Rosenberg; Su Mi Choi; Karen Fox-Talbot; Angelo M De Marzo; Larisa Nonn; W Nathaniel Brennen; Luigi Marchionni; Marc K Halushka; Shawn E Lupold
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

Review 6.  MicroRNAs as Guardians of the Prostate: Those Who Stand before Cancer. What Do We Really Know about the Role of microRNAs in Prostate Biology?

Authors:  Thomas Andl; Kavya Ganapathy; Alexia Bossan; Ratna Chakrabarti
Journal:  Int J Mol Sci       Date:  2020-07-07       Impact factor: 5.923

Review 7.  The regulatory pathways leading to stem-like cells underlie prostate cancer progression.

Authors:  Chun-Jung Lin; U-Ging Lo; Jer-Tsong Hsieh
Journal:  Asian J Androl       Date:  2019 May-Jun       Impact factor: 3.285

8.  IDH1R132H Promotes Malignant Transformation of Benign Prostatic Epithelium by Dysregulating MicroRNAs: Involvement of IGF1R-AKT/STAT3 Signaling Pathway.

Authors:  Lili Zhang; Mei Qi; Tingting Feng; Jing Hu; Lin Wang; Xinjun Li; Wei Gao; Hui Liu; Meng Jiao; Zhen Wu; Xinnuo Bai; Yifan Bie; Long Liu; Bo Han
Journal:  Neoplasia       Date:  2018-01-12       Impact factor: 5.715

9.  MiR-346 suppresses cell proliferation through SMYD3 dependent approach in hepatocellular carcinoma.

Authors:  Weiyou Zhu; Jing Qian; Ling Ma; Pei Ma; Fengming Yang; Yongqian Shu
Journal:  Oncotarget       Date:  2017-05-22

Review 10.  Coordinated AR and microRNA regulation in prostate cancer.

Authors:  Ieva Eringyte; Joanna N Zamarbide Losada; Sue M Powell; Charlotte L Bevan; Claire E Fletcher
Journal:  Asian J Urol       Date:  2020-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.